OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 10.3
Unit: Days
Value type: Unspecified
Uncertainty single value: 5.1 ()
Combined uncertainty: 5.1 ()
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 62
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Other delay start: Symptom Onset/Fever
Other delay end: Symptom Resolution
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Cormobidity;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 87
Sample size: 76
Country: Taiwan,  China
Location: NTUH, Northern Taiwan
Study period: 8 Mar-03 2003 to 15 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - latent period
Parameter value: 5
Unit: Days
Value type: Mean
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 19 Apr-04 2003 to 21 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.37
Unit: No units
Value type: Unspecified
Epidemic phase: Unspecified
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 19 Apr-04 2003 to 21 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.1
Unit: No units
Value type: Unspecified
Epidemic phase: End outbreak
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 19 Apr-04 2003 to 21 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - infectious period
Parameter value: 4
Unit: Days
Value type: Mean
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 19 Apr-04 2003 to 21 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 0.41
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 9
CFR/IFR denominator: 2197
Epidemic phase: End outbreak
Disaggregated by: Occupation, Sex
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 2197
Country: Taiwan,  China
Study period: 1 Jul-07 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Occupation
Risk factor outcome: Serology
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 2197
Country: Taiwan,  China
Study period: 1 Jul-07 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Occupation;Sex
Risk factor outcome: Serology
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 2197
Country: Taiwan,  China
Study period: 1 Jul-07 2003 to
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 1.02
CFR/IFR numerator: 9
CFR/IFR denominator: 882
Epidemic phase: End outbreak
Disaggregated by: Occupation, Sex
Population group: Healthcare workers
Sample type: Contact based
Sex: Both
Sample size: 882
Country: Taiwan,  China
Study period: 1 Jul-07 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Occupation
Risk factor outcome: Serology
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Contact based
Sex: Both
Sample size: 882
Country: Taiwan,  China
Study period: 1 Jul-07 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Occupation;Sex
Risk factor outcome: Serology
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Contact based
Sex: Both
Sample size: 882
Country: Taiwan,  China
Study period: 1 Jul-07 2003 to
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 3.6
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 3.1
Uncertainty upper value: 4.2
Combined uncertainty: 3.1 - 4.2 (95% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Hong Kong SAR
Study period:  Feb-02 2003 to 11 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 2.4
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 1.8
Uncertainty upper value: 3.1
Combined uncertainty: 1.8 - 3.1 (95% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Vietnam
Study period:  Feb-02 2003 to 11 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 3.1
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 2.3
Uncertainty upper value: 4
Combined uncertainty: 2.3 - 4 (95% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Singapore
Study period:  Feb-02 2003 to 11 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 2.7
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 1.8
Uncertainty upper value: 3.6
Combined uncertainty: 1.8 - 3.6 (95% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Canada
Study period:  Feb-02 2003 to 11 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.7
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0.7
Uncertainty upper value: 0.8
Combined uncertainty: 0.7 - 0.8 (95% CI)
Epidemic phase: Mid outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Hong Kong SAR
Study period: 12 Mar-03 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.3
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0.1
Uncertainty upper value: 0.7
Combined uncertainty: 0.1 - 0.7 (95% CI)
Epidemic phase: Mid outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Vietnam
Study period: 12 Mar-03 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.7
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0.6
Uncertainty upper value: 0.9
Combined uncertainty: 0.6 - 0.9 (95% CI)
Epidemic phase: Mid outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Singapore
Study period: 12 Mar-03 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 1
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0.9
Uncertainty upper value: 1.2
Combined uncertainty: 0.9 - 1.2 (95% CI)
Epidemic phase: Mid outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Canada
Study period: 12 Mar-03 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 9.7
Unit: Percentage (%)
CFR/IFR numerator: 6
CFR/IFR denominator: 62
CFR/IFR method: Naive
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 24.5
Unit: Days
Value type: Mean
Uncertainty single value: 7.4 (Standard Deviation)
Combined uncertainty: 7.4 (Standard Deviation)
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 10.5
Unit: Days
Value type: Mean
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Other delay start: Symptom Onset/Fever
Other delay end: Other: Intubation
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 12.7
Unit: Days
Value type: Mean
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Other delay start: Symptom Onset/Fever
Other delay end: Symptom Resolution
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 18.8
Unit: Days
Value type: Mean
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4.3
Unit: Days
Value type: Mean
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 98.4
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 61
CFR/IFR denominator: 62
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 76
Sample size: 62
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 0
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 0
CFR/IFR denominator: 127
Epidemic phase: Unspecified
Disaggregated by: Symptoms
Population group: Persons under investigation
Sample type: Travel based
Sex: Unspecified
Sample size: 127
Country: United States
Location: Seven US-bound aircraft. Follow ups across USA
Study period: 23 Feb-02 2003 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 302
CFR/IFR denominator: 1755
CFR/IFR method: Naive
Disaggregated by: Age, Occupation, Sex
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 1755
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Disaggregated by: Other
Risk factor: Sex;Age;Occupation
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 1755
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 3.7
Unit: Days
Value type: Mean
Uncertainty type: 95% CrI
Uncertainty lower value: 2.6
Uncertainty upper value: 5.8
Combined uncertainty: 2.6 - 5.8 (95% CrI)
Disaggregated by: Other
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 302
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.8
Unit: Days
Value type: Mean
Uncertainty type: 95% CrI
Uncertainty lower value: 4.2
Uncertainty upper value: 5.5
Combined uncertainty: 4.2 - 5.5 (95% CrI)
Disaggregated by: Other
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 1453
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.7
Unit: Days
Value type: Mean
Uncertainty type: 95% CrI
Uncertainty lower value: 4.1
Uncertainty upper value: 5.4
Combined uncertainty: 4.1 - 5.4 (95% CrI)
Distribution type: Normal-Log
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 234
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.6
Unit: Days
Value type: Standard Deviation
Uncertainty type: 95% CrI
Uncertainty lower value: 3.6
Uncertainty upper value: 6
Combined uncertainty: 3.6 - 6 (95% CrI)
Distribution type: Normal-Log
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 234
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Disaggregated by: Other
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 1755
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Disaggregated by: Other
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 308
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Disaggregated by: Other
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 234
Country: Hong Kong SAR,  China
Study period:  Feb-02 2003 to  Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Parameter value: 5.7
Unit: Unspecified
Value type: Unspecified
Epidemic phase: Unspecified
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 6
Country: Singapore
Study period:    to   2003
Genome site: whole genome
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Parameter value: 4.3
Unit: Unspecified
Value type: Unspecified
Epidemic phase: Unspecified
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 12
Country: Singapore
Study period:    to   2003
Genome site: whole genome
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5
Unit: Days
Value type: Mean
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 10
Combined uncertainty: 2 - 10 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 42
Country: Canada
Location: Toronto
Study period: 14 Mar-03 2003 to 15 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 10.3
Upper bound: 60
Bounds: 10.3 - 60
Epidemic phase: Unspecified
Disaggregated by: Occupation
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Country: Canada
Location: Toronto
Study period: 14 Mar-03 2003 to 15 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 10
Combined uncertainty: 2 - 10 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 42
Country: Canada
Location: Toronto
Study period: 14 Mar-03 2003 to 15 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 13.3
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 90
Bounds: 0 - 90
CFR/IFR numerator: 17
CFR/IFR denominator: 128
CFR/IFR method: Naive
Epidemic phase: Unspecified
Disaggregated by: Age, Other
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 1.75
Maximum age: 86
Sample size: 128
Country: Canada
Location: Toronto
Study period: 14 Mar-03 2003 to 10 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 24.8
Unit: Days
Value type: Mean
Uncertainty type: Range
Uncertainty lower value: 9
Uncertainty upper value: 57
Combined uncertainty: 9 - 57 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 38
Maximum age: 86
Sample size: 17
Country: Canada
Location: Toronto
Study period: 14 Mar-03 2003 to 15 Apr-04 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Parameter value: 10.2
Unit: Percentage (%)
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 6.7
Uncertainty upper value: 23.5
Combined uncertainty: 6.7 - 23.5 (95% CI)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Household based
Sex: Both
Minimum age: 1
Maximum age: 79
Sample size: 176
Country: Canada
Location: Toronto, York Region, Ontario
Study period: 25 May-05 2003 to 31 Oct-10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Occupation;Other;Close contact
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Household based
Sex: Both
Minimum age: 1
Maximum age: 79
Sample size: 176
Country: Canada
Location: Toronto, York Region, Ontario
Study period: 25 May-05 2003 to 31 Oct-10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other;Close contact
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Household based
Sex: Both
Minimum age: 1
Maximum age: 79
Sample size: 176
Country: Canada
Location: Toronto, York Region, Ontario
Study period: 25 May-05 2003 to 31 Oct-10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Occupation
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Household based
Sex: Both
Minimum age: 1
Maximum age: 79
Sample size: 176
Country: Canada
Location: Toronto, York Region, Ontario
Study period: 25 May-05 2003 to 31 Oct-10 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Occupation;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Household based
Sex: Both
Minimum age: 1
Maximum age: 79
Sample size: 176
Country: Canada
Location: Toronto, York Region, Ontario
Study period: 25 May-05 2003 to 31 Oct-10 2003